January 10, 2008 – 10:20 pm
Submitted by Biotechman and Optiondragon
Earlier this week, Biogen Idec Inc. and partner Elan Corp forecasted that by 2010 it would have 100,000 patients taking Tysabri, which costs $29,400 per year. Biogen believes that sales growth in 2008 will be mostly coming from Tysarbi. They also said recently that as of the end of September there have […]
January 10, 2008 – 7:15 pm
The market continued to push upwards from yesterday’s bounce. The Dow gained +117.78 points; SPX added +11.20 points; and Nasdaq was up almost +14 points.
The Fed Chairman, Ben Bernanke, signaled further interest rate cuts to support economic growth. The market reacted very well, initially, as eager investors tried to catch the “Uncle Ben […]